Specialties
Cartilage
Specialties
Hip
Specialties
Pelvis
Specialties
Regenerative Medicine
Specialties
Shoulder
547 results found in 10ms
ChondroFiller injection versus knee replacement for focal defectsChondroFiller injection versus knee replacement for focal defects
ChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.ChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.
ChondroFiller™ durability compared with ArthrosamidChondroFiller™ durability compared with Arthrosamid
ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.
Who qualifies for ChondroFiller injectionWho qualifies for ChondroFiller injection
ChondroFiller injects a collagen scaffold into focal cartilage lesions—typically grade III–IV defects under 6 cm²—to recruit the patient's progenitor cells for repair rather than replacing tissue artificially.ChondroFiller injects a collagen scaffold into focal cartilage lesions—typically grade III–IV defects under 6 cm²—to recruit the patient's progenitor cells for repair rather than replacing tissue artificially.
ChondroFiller injection cost in the UKChondroFiller injection cost in the UK
ChondroFiller injection costs £3,000–£9,800 depending on cartilage defect size; the NHS does not fund it, and quoted prices bundle assessment, imaging, injection, and six-week follow-up.ChondroFiller injection costs £3,000–£9,800 depending on cartilage defect size; the NHS does not fund it, and quoted prices bundle assessment, imaging, injection, and six-week follow-up.
ChondroFiller injection for knee cartilage defectsChondroFiller injection for knee cartilage defects
The injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.The injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.
Ultrasound-Guided ChondroFiller for Hip Cartilage DefectsUltrasound-Guided ChondroFiller for Hip Cartilage Defects
An injectable collagen scaffold recruits the patient's own cells to repair hip cartilage defects; clinical cohorts report 70–85% achieve meaningful symptom relief at 3–5 years, though success requires absence of pre-existing moderate-to-severe osteoarthritis.An injectable collagen scaffold recruits the patient's own cells to repair hip cartilage defects; clinical cohorts report 70–85% achieve meaningful symptom relief at 3–5 years, though success requires absence of pre-existing moderate-to-severe osteoarthritis.
ChondroFiller injection for talar osteochondral lesionsChondroFiller injection for talar osteochondral lesions
An ultrasound-guided collagen scaffold injected in clinic, ChondroFiller recruits the patient's own progenitor cells to repair focal cartilage defects on the talar dome that persist despite at least six months of conservative care.An ultrasound-guided collagen scaffold injected in clinic, ChondroFiller recruits the patient's own progenitor cells to repair focal cartilage defects on the talar dome that persist despite at least six months of conservative care.
ChondroFiller injection versus cartilage surgeryChondroFiller injection versus cartilage surgery
ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.
What separates ChondroFiller from Liquid CartilageWhat separates ChondroFiller from Liquid Cartilage
ChondroFiller is a single collagen scaffold delivered two ways: as an outpatient injection alone, or combined with patient-derived cells under the clinical brand Liquid Cartilage™. Naming overlap at clinics obscures which is being offered.ChondroFiller is a single collagen scaffold delivered two ways: as an outpatient injection alone, or combined with patient-derived cells under the clinical brand Liquid Cartilage™. Naming overlap at clinics obscures which is being offered.
ChondroFiller injection safety and the questions to askChondroFiller injection safety and the questions to ask
ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.
ChondroFiller versus hyaluronic acid for cartilage defectsChondroFiller versus hyaluronic acid for cartilage defects
ChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.ChondroFiller fills discrete cartilage defects using a cell-recruiting scaffold; hyaluronic acid treats diffuse osteoarthritis through joint lubrication. They address different pathologies, and the choice depends on imaging, not on how much pain a patient experiences.
ChondroFiller NHS status and private access routesChondroFiller NHS status and private access routes
ChondroFiller is not available on the NHS, pending formal health technology assessment; private, self-funded treatment is the sole current UK access route.ChondroFiller is not available on the NHS, pending formal health technology assessment; private, self-funded treatment is the sole current UK access route.
547 results found in 10ms